UK cancer research bodies agree commercial "skills swap"
This article was originally published in Clinica
Executive Summary
The commercial arms of charity Cancer Research UK (CRUK) and of the UK government's Medical Research Council (MRC) yesterday signed an agreement to swap R&D rights. The initiative promises to "accelerate the translation of early scientific research into patient benefit", in diagnostics as well as therapeutics, Clinica has learnt.